Loading...
Back to narrative

Update shared on20 Sep 2025

Fair value Decreased 1.30%
AnalystConsensusTarget's Fair Value
JP¥3,522.00
24.1% undervalued intrinsic discount
05 Oct
JP¥2,672.00
Loading
1Y
-10.0%
7D
2.3%

Nidec’s fair value estimate was marginally reduced, as both its future P/E and discount rate remained essentially stable, resulting in only a slight decrease in the consensus analyst price target from ¥3618 to ¥3571.


What's in the News


  • Nidec will hold a Board Meeting with an agenda to consider establishing a third-party committee.
  • The company has delayed the release of its Q1 FY26 financial results due to ongoing investigations into trade and customs issues at a subsidiary, impacting the finalization of FY25 accounts and causing postponement of Q1 FY26 disclosure.
  • No shares were repurchased in the latest buyback tranche, with zero shares acquired and zero expenditure.

Valuation Changes


Summary of Valuation Changes for Nidec

  • The Consensus Analyst Price Target remained effectively unchanged, moving only marginally from ¥3618 to ¥3571.
  • The Future P/E for Nidec remained effectively unchanged, moving only marginally from 20.56x to 20.33x.
  • The Discount Rate for Nidec remained effectively unchanged, moving only marginally from 7.48% to 7.55%.

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.